Clinical Trial Update: Dovitinib Plus Docetaxel in Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the combination of dovitinib and docetaxel in gastric cancer has been completed. The report summarizes the results from this study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Dovitinib (dovitinib)

Snippet

Sponsor: Asan Medical Center | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: COMPLETED